4Filing Date: Aug 26, 2026

Boston Scientific (BSX)

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0001225208-26-007337
Total Value$100.4K
Trades1
Insiders1

Transaction Details

Morano Susan E
Director·Direct
Buy · Acquire
Common Stock
Shares+2.04K
Price$49.22
Total Value$100.4K
Shares Owned After13.78K
Transaction DateAug 25, 2026

Post-Transaction Holdings

Morano Susan E · Director
SecuritySharesChange
Common Stock13.78K+2.04K (17.37%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-08-25 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: BOSTON SCIENTIFIC CORP (BSX) CIK: 0000885725 --- Reporting Owner --- Name: Morano Susan E CIK: 0001983791 Role: Director --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-08-25 | Code: P (Open market purchase) Shares: +2,040 | Price: $49.22 Total Value: $100,407.78 Shares Owned After: 13,784 | Ownership: D (Direct) --- Signature --- /s/ /s/ Susan Thompson, Attorney-in-Fact (2026-08-26)

keid analysis is for reference only and does not constitute investment advice.